Related Experiment Video
Updated: Jul 8, 2025

Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model
Published on: July 28, 2023
Approach to Congenital Diarrhea and Enteropathies (CODEs)
Teera Kijmassuwan1,2, Fariha Balouch3
1Division of Gastroenterology, Department of Pediatrics, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Insights
Congenital diarrhea and enteropathies (CODEs) are rare genetic disorders causing severe infant diarrhea and malabsorption. Early diagnosis and genetic testing are crucial for timely management and preventing life-threatening complications.
Area of Science:
- Pediatric Gastroenterology
- Clinical Genetics
- Rare Diseases
Background:
- Congenital diarrhea and enteropathies (CODEs) are rare genetic disorders presenting with severe diarrhea and malabsorption in infancy.
- Prompt diagnosis and intervention are vital to prevent dehydration, electrolyte imbalance, malnutrition, and developmental delay.
Purpose of the Study:
- To provide a simplified diagnostic approach for CODEs.
- To highlight key diagnostic modalities, including next-generation sequencing (NGS).
- To focus on specific CODEs: microvillus inclusion disease (MVID), congenital tufting enteropathy (CTE), congenital chloride diarrhea (CLD), and congenital sodium diarrhea (CSD).
Main Methods:
- Review of diagnostic strategies for CODEs.
- Emphasis on differentiating CODEs from infectious, allergic, or anatomical causes.
- Inclusion of stool tests, blood tests, immunological studies, endoscopy, biopsies (histology, electron microscopy), and NGS.
Main Results:
- CODEs present with severe watery/bloody diarrhea, steatorrhea, dehydration, poor growth, and developmental delay.
- NGS is pivotal for identifying causative genetic mutations.
- Treatment is limited, often requiring total parenteral nutrition; intestinal transplantation is an option for severe cases.
Conclusions:
- Early recognition and accurate diagnosis of CODEs are paramount for effective management.
- Advancements in genetic testing are crucial for improving diagnostic accuracy and developing targeted therapies.
- Long-term prognosis varies, with potential for ongoing intestinal failure.
Abstract:
Congenital diarrhea and enteropathies (CODEs) constitute a group of rare genetic disorders characterized by severe diarrhea and malabsorption in the neonatal period or early infancy. Timely diagnosis and treatment is essential to prevent life-threatening complications, including dehydration, electrolyte imbalance, and malnutrition. This review offers a simplified approach to the diagnosis of CODEs, with a specific focus on microvillus inclusion disease (MVID), congenital tufting enteropathy (CTE), congenital chloride diarrhea (CLD), and congenital sodium diarrhea (CSD). Patients with CODEs typically present with severe watery or occasionally bloody diarrhea, steatorrhea, dehydration, poor growth, and developmental delay. Therefore, it is crucial to thoroughly evaluate infants with diarrhea to rule out infectious, allergic, or anatomical causes before considering CODEs as the underlying etiology. Diagnostic investigations for CODEs encompass various modalities, including stool tests, blood tests, immunological studies, endoscopy and biopsies for histology and electron microscopy, and next-generation sequencing (NGS). NGS plays a pivotal role in identifying the genetic mutations responsible for CODEs. Treatment options for CODEs are limited, often relying on total parenteral nutrition for hydration and nutritional support. In severe cases, intestinal transplantation may be considered. The long-term prognosis varies among specific CODEs, with some patients experiencing ongoing intestinal failure and associated complications. In conclusion, the early recognition and accurate diagnosis of CODEs are of paramount importance for implementing appropriate management strategies. Further research and advancements in genetic testing hold promise for enhancing diagnostic accuracy and exploring potential targeted therapies for these rare genetic disorders.
Related Concept Videos
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

